Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 1, 2026

Jul. 1, 2026

Medline to report second quarter 2026 results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

NBT Bancorp Inc. Announces Date of Second Quarter Conference Call

Indeterminate GlobeNewswire

Jul. 1, 2026

Bit Origin Announces Balance Sheet Strengthening Following Strategic AI Infrastructure Acquisition

Indeterminate GlobeNewswire

Jul. 1, 2026

ibex Honors the Winners of the 5th Annual CX Leadership Awards at CCW Las Vegas

Indeterminate GlobeNewswire

Jul. 1, 2026

Creative Medical Technology Holdings Issues Mid-Year Update

Indeterminate GlobeNewswire

Jul. 1, 2026

Cuentas Executives Double Down on the Company’s Future with Open-Market Stock Purchases

Indeterminate GlobeNewswire

Jul. 1, 2026

Türkiye’s leading digital asset platform Paribu expands its platform into DeFi, yield, and equities

Indeterminate GlobeNewswire

Jul. 1, 2026

A Supersonic Jet Fleet, a Step-by-Step Path to Orbit, and a New Spot in the Russell 3000: Inside Starfighters Space’s Plan

Indeterminate GlobeNewswire

Jul. 1, 2026

Berto Acquisition Corp. II Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about July 6, 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

Wikitree Selects DeeperDive From Taboola, Gen AI Answer Engine Built for the Open Web, to Connect Readers with Timely, Contextual Answers for Topics They Care About

Indeterminate GlobeNewswire

Jul. 1, 2026

MathCo Expands Databricks Center of Excellence to Help Retail and CPG Enterprises Operationalize Agentic AI

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform

Indeterminate GlobeNewswire